Patents/Assignees

H. Lundbeck A/S

62 patents in portfolio

US12590106utility2026
Spiromacrocyclic Orexin 2 Receptor Agonists
0 cites
US12590142utility2026
Antibody Purification and Purity Monitoring
0 cites
US12545725utility2026
Anti-pacap Antibodies, Nucleic Acids and Methods of Making Thereof
0 cites
US12508239utility2025
Alcohol Derivatives as Kv7 Potassium Channel Openers for Use in Epilepsy or Seizures
0 cites
US12479801utility2025
Process for the Manufacturing of (6ar,10ar)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-g]quinoline and (4ar,10ar)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol
0 cites
US12428475utility2025
Humanized Anti-acth Antibodies and Use Thereof
0 cites
US12421271utility2025
Solid Forms of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar, 10ar)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-carboxylic Acid
0 cites
US12421303utility2025
Agents, Uses and Methods for the Treatment of Synucleinopathy
0 cites
US12398106utility2025
Catecholamine Carbamate Prodrugs for Use in the Treatment of Parkinson's Disease
0 cites
US12398169utility2025
Process for the Manufacture of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-carboxylic Acid
0 cites
US12391650utility2025
Catecholamine Prodrugs for Use in the Treatment of Parkinson's Disease
0 cites
US12391749utility2025
Acute Treatment and Rapid Treatment of Headache Using Anti-cgrp Antibodies
0 cites
US12384765utility2025
Catecholamine Prodrugs for Use in the Treatment of Parkinson's Disease
0 cites
US12384836utility2025
Treatment of Headache Using Anti-cgrp Antibodies
0 cites
US12384837utility2025
Treatment of Most Bothersome Symptom (MBS) Associated with Migraine Using Anti-cgrp Antibodies
0 cites
US12378219utility2025
Crystalline Forms of a MAGL Inhibitor
0 cites
US12358974utility2025
Compositions and Methods for Treating Synucleinopathies
0 cites
US12358975utility2025
Compositions and Methods for Treating Synucleinopathies
0 cites
US12351627utility2025
Anti-acth Antibodies and Use Thereof
0 cites
US12351624utility2025
Compositions and Methods for Treating Synucleinopathies
0 cites

Page 1 of 4Next →